Browse the latest research summaries in the field of covid-19 for spinal cord injury patients and caregivers.
Showing 61-70 of 77 results
Spinal Cord, 2023 • November 24, 2022
This study investigated the impact of changes in essential care during the COVID-19 pandemic on individuals with spinal cord injury (SCI). It focused on satisfaction with activities, participation, an...
KEY FINDING: Decreased access to mental health support was associated with decreased satisfaction in mobility, participation in recreational activities, and relationships with family and friends.
Spinal Cord Series and Cases, 2023 • February 14, 2023
This study examined the lived experiences of persons with spinal cord injury (PWSCI) and their caregivers transitioning from inpatient rehabilitation to the community during the COVID-19 pandemic. The...
KEY FINDING: Dyads described transition experiences from inpatient rehabilitation to community as uncertain and unsupported.
Spinal Cord Series and Cases, 2020 • August 5, 2020
The letter highlights the barriers to personal hygiene in persons with Spinal Cord Injury (SCI) during the COVID-19 pandemic and lockdown in India, emphasizing their increased susceptibility to infect...
KEY FINDING: Mobility restrictions directly hinder hand hygiene for individuals with SCI, and pre-existing skin infections require more vigorous hygienic practices.
Spine Surg Relat Res, 2023 • June 9, 2023
This retrospective study analyzed 231 patients who underwent SCI surgery between 2017 and 2021 to determine the predictors of delirium after surgery. The study found that age, treatment during the COV...
KEY FINDING: Age ≥73 years, treatment during the COVID-19 pandemic, and psychiatric disorders were identified as independent risk factors for delirium after SCI surgery.
JACEP Open, 2020 • September 24, 2020
Individuals with SCI/D are at much higher risk of complications of respiratory infections including the more rapid onset of respiratory failure and death due to respiratory muscle paralysis, other chr...
KEY FINDING: Persons with SCI/D have greater mortality from pneumonia and influenza compared to the general population with the standardized mortality ratio for pneumonia and influenza for all types of SCI/D calculated approximately 40.2,3
Spinal Cord, 2020 • May 13, 2020
The correspondence addresses the significant demands on healthcare resources caused by the COVID-19 crisis, especially concerning patients with spinal cord injuries. It highlights the increased risk f...
KEY FINDING: Patients with SCI, especially those with tetraplegia or high-level paraplegia, are at increased risk of severe complications from COVID-19 due to reduced lung function.
European Journal of Trauma and Emergency Surgery, 2021 • July 22, 2020
This study analyzed the impact of the COVID-19 quarantine on traumatic brain injury (TBI) cases in Tyrol, Austria, by comparing data from the 2020 lockdown period with the same period in 2016–2019. Th...
KEY FINDING: The weekly number of TBI patients decreased significantly during the strict quarantine in 2020 compared to 2016, 2018, and 2019.
Cell Discovery, 2021 • January 1, 2021
This study comprehensively investigates pathophysiological and immunological changes in healthy volunteers after COVID-19 vaccination with an inactivated SARS-CoV-2 vaccine. The findings reveal consis...
KEY FINDING: Vaccination with an inactivated SARS-CoV-2 vaccine induces consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions.
Brain and Spine, 2025 • December 9, 2024
The study investigated the impact of COVID-19 lockdowns and restrictions on the incidence of traumatic brain injuries (TBI) in Tyrol, Austria, comparing TBI rates during lockdown periods in 2020 and 2...
KEY FINDING: During the first lockdown in the winter of 2020/2021, there was a notably lower incidence of moderate and severe TBIs compared to the corresponding period in 2019/2020 (p = 0.016).
Cytotherapy, 2020 • May 2, 2020
This statement addresses the potential use of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) as a therapeutic approach for COVID-19, highlighting both the promise and the potential ...
KEY FINDING: MSC-EVs do not necessarily suppress immune responses, but rather modulate them, specifically moderating acute immune responses toward regulatory responses, inducing tolerance, and restoring homeostasis.